Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer

Lung Cancer

Volumn 62, Issue 3, 2008, Pages 295-301

  Zhang, Siyang ^a   Qiu, Xueshan ^a   Gu, Yumei ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ERK1 2; Expression and activation; Metastasis; NSCLC; PYK2

Indexed keywords

FOCAL ADHESION KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 56949090552     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.05.008     Document Type: Article

References (25)

1. 2+-dependent, cytosolic tyrosine kinase PYK2. Ann N Y Acad Sci 1090 (2006) 385-398
2. Schindler E.M., Baumgartner M., Gribben E.M., Li L., and Efimova T. The role of proline-rich protein tyrosine kinase 2 in differentiation-dependent signaling in human epidermal keratinocytes. J Invest Dermatol 127 (2007) 1094-1106
3. Park S.Y., Li H., and Avraham S. RAFTK/PYK2 regulates EGF-induced PC12 cell spreading and movement. Cell Signal 19 (2007) 289-300
4. Gutenberg A., Bruck W., Buchfelder M., and Ludwig H.C. Expression of tyrosine kinases FAK and PYK2 in 331 human astrocytomas. Acta Neuropathol (Berl) 108 (2004) 224-230
5. Sun C.K., Ng K.T., Sun B.S., Ho J.W., Lee T.K., Ng I., et al. The significance of proline-rich tyrosine kinase 2 (PYK2) on hepatocellular carcinoma progression and recurrence. Br J Cancer 97 (2007) 50-57
6. Wei L., Yang Y., Zhang X., and Yu Q. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 23 (2004) 9052-9061
7. Yuan T.C., Lin F.F., Veeramani S., Chen S.J., Earp H.S.3r., and Lin M.F. ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene 26 (2007) 7552-7559
8. Lipinski C.A., Tran N.L., Menashi E., Rohl C., Kloss J., Bay R.C., et al. The tyrosine kinase PYK2 promotes migration and invasion of glioma cells. Neoplasia 7 (2005) 435-445
9. Fernandis A.Z., Prasad A., Band H., Klösel R., and Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23 (2004) 157-167
10. Zrihan-Licht S., Fu Y., Settleman J., Schinkmann K., Shaw L., Keydar I., et al. RAFTK/PYK2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19 (2000) 1318-1328
11. McShan G.D., Zagozdzon R., Park S.Y., Zrihan-Licht S., Fu Y., Avraham S., et al. Csk homologous kinase associates with RAFTK/PYK2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration. Int J Oncol 21 (2000) 197-205
12. Boutahar N., Guignandon A., Vico L., and Lafage-Proust M.H. Mechanical strain on osteoblasts activates autophosphorylation of focal adhesion kinase and proline-rich tyrosine kinase 2 tyrosine sites involved in ERK activation. J Biol Chem 279 (2004) 30588-30599
13. Basile J.R., Gavard J., and Gutkind J.S. Plexin-B1 utilizes RHOA and ROK to promote the integrin-dependent activation of AKT and ERK, and endothelial cell motility. J Biol Chem 282 (2007) 34888-34895
14. Rocic P., Govindarajan G., Sabri A., and Lucchesi P.A. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI3-kinase by ANG II in vascular smooth muscle. Am J Physiol Cell Physiol 280 (2001) C90-C99
15. Zrihan-Licht S., Avraham S., Jiang S., Fu Y., and Avraham H.K. Coupling of RAFTK/PYK2 kinase with c-Abl and their role in the migration of breast cancer cells. Int J Oncol 24 (2004) 153-159
16. Zhu W., Zheng J., and Fang W. Isolation and charaterization of human lung cancer cell subline with different metastatic potential. Chin J Pathol 24 (1995) 136-138
17. Park S.Y., Avraham H.K., and Avraham S. RAFTK/PYK2 activation is mediated by trans-acting autophosphorylation in a Src-dependent manner. J Biol Chem 279 (2004) 33315-33322
18. Picascia A., Stanzione R., Chieffi P., Kisslinger A., Dikic I., and Tramontano D. Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells. Mol Cell Endocrinol 186 (2002) 81-87
19. Lipinski C.A., Tran N.L., Bay C., Kloss J., McDonough W.S., Beaudry C., et al. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 1 (2003) 323-332
20. Rucci N., Ricevuto E., Ficorella C., Longo M., Perez M., Di Giacinto C., et al. In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells. Bone 34 (2004) 697-709
21. Li X., Dy R.C., Cance W.G., Graves L.M., and Earp H.S. Interaction between two cytoskeleton-associated tyrosine kinases: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase. J Biol Chem 274 (1999) 8917-8924
22. Tang H., Hao Q., Fitzgerald T., Sasaki T., Landon E.J., and Inagami T. PYK2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J Biol Chem 277 (2002) 5441-5447
23. Kuwabara K., Nakaoka T., Sato K., Nishishita T., Sasaki T., and Yamashita N. Differential regulation of cell migration and proliferation through proline-rich tyrosine kinase 2 in endothelial cells. Endocrinology 145 (2004) 3324-3330
24. Lipinski C.A., Tran N.L., Dooley A., Pang Y.P., Rohl C., Kloss J., et al. Critical role of the FERM domain in PYK2 stimulated glioma cell migration. Biochem Biophys Res Commun 349 (2006) 939-947
25. Roelle S., Grosse R., Buech T., Chubanov V., and Gudermann T. Essential role of PYK2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 27 (2008) 1737-1748